Monocyte‐Derived Alveolar Macrophages in ALI / ARDS : The Core Drivers of Inflammation
Immunology · 2026-07 · 178 (3) · 401-416
DOI: 10.1111/imm.70125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 23.02.2026. Verfasst von Zhouli Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Sixth Medical Center of Chinese, PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Respiratory Distress Syndrome, Acute Lung Injury, Inflammation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 168 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a deadly disorder with poor therapeutic opportunities, driven by dysregulated immunity. Here we position monocyte‐derived alveolar macrophages (Mo‐AMs) as central mediators of ALI/ARDS pathogenesis, contrasting with homeostatic tissue‐resident alveolar macrophages (TR‐AMs). This review first traces the origin pathway of Mo‐AMs, which differentiate from haematopoietic stem cells (HSCs) in the bone marrow and are recruited to the inflamed lung via a CCR2/CCL2‐dependent pathway, ultimately differentiating into pathogenic effector cells within the alveolar microenvironment. Subsequently, we elucidate their primary pathogenic mechanisms: Mo‐AMs mediate critical pathological injury by generating cytokine storms, depleting TR‐AMs, disrupting the alveolar‐capillary barrier and promoting fibrotic remodelling. Given their well‐defined pathogenic role, Mo‐AMs have emerged as a promising therapeutic target. Therefore, we conclude by reviewing recent advances in strategies targeting Mo‐AMs, primarily encompassing the inhibition of their recruitment, induction of their apoptosis and reprogramming of their proinflammatory functions. These approaches collectively provide valuable insights for developing novel therapies for ALI/ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Sixth Medical Center of Chinese, PLA General Hospital, Beijing, China.
- The Fifth School of Clinical Medicine, Anhui Medical University, Hefei, China.
- Navy Clinical College, Anhui Medical University, Beijing, China.
ORCID-Profile: Zhouli Tan
Förderung
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Tan, Z., Ding, Y., Chen, W., Zhang, C., Han, Z., & Chen, X. (2026). Monocyte‐Derived Alveolar Macrophages in ALI / ARDS : The Core Drivers of Inflammation. Immunology, 178(3), 401-416. https://doi.org/10.1111/imm.70125
Vancouver
Tan Z, Ding Y, Chen W, Zhang C, Han Z, Chen X. Monocyte‐Derived Alveolar Macrophages in ALI / ARDS : The Core Drivers of Inflammation. Immunology. 2026;178(3):401-416. doi:10.1111/imm.70125
BibTeX
@article{Tan2026,
author = {Tan, Zhouli and Ding, Yiwei and Chen, Wei and Zhang, Chunyang and Han, Zhihai and Chen, Xuxin},
title = {Monocyte‐Derived Alveolar Macrophages in ALI / ARDS : The Core Drivers of Inflammation},
journal = {Immunology},
year = {2026},
volume = {178},
number = {3},
pages = {401--416},
doi = {10.1111/imm.70125}
}
EUVIMED